TKAAPP Research

Prospective randomized trial for effects of Alaska Pollack protein for locomotion after Total Knee Arthroplasty - TKAAPP Research

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs061190009

Enrollment

100

Registered

2019-07-02

Start date

2019-10-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of knee joint

Interventions

Treated with 4.5 g/day of protein derived from whey or APP.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients treated with Total Knee Arthroplasty

Exclusion criteria

Exclusion criteria: Palsy of lower extremities, Renal dysfunction, Hepatic dysfunction

Design outcomes

Primary

Measure	Time frame
Difference of muscular function of lower extremities	—

Secondary

Measure	Time frame
Difference of locomotive syndrome score	—

Contacts

Public ContactYuuki Imai

Ehime University Graduate School of Medicine

y-imai@m.ehime-u.ac.jp+81-89-960-5925

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026